{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:24Z","timestamp":1761058284277},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T00:00:00Z","timestamp":1116288000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> In this study, we measured the levels of eosinophil cationic protein (ECP) and interleukin (IL)\u20108 in bronchoalveolar lavage (BAL) fluid from patients with acute asthma and acute bronchiolitis, to determine any similarities or dissimilarities in the profiles of these biochemical markers in the two diseases.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> BAL fluids were obtained from children with acute asthma (<jats:italic>n<\/jats:italic>=16), infants with acute bronchiolitis caused by respiratory syncytial virus (<jats:italic>n<\/jats:italic>=18), and control subjects (<jats:italic>n<\/jats:italic>=14). Children with asthma were selected to be free of viral infection. BAL cell counts and differentials were determined, and ECP and IL\u20108 levels were measured by radioimmunoassay and ELISA, respectively.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> ECP levels in BAL fluids were significantly higher in the asthma group than in the bronchiolitis (<jats:italic>P<\/jats:italic>&lt;0.01) or control (<jats:italic>P<\/jats:italic>&lt;0.0001) groups. However, IL\u20108 levels were significantly higher in the bronchiolitis group than in the asthma (<jats:italic>P<\/jats:italic>&lt;0.01) or control (<jats:italic>P<\/jats:italic>&lt;0.001) groups. IL\u20108 levels in the asthma group and ECP levels in the bronchiolitis group were similar to those of the control group.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> This difference in profiles of ECP and IL\u20108 in acute asthma and acute bronchiolitis, together with a different inflammatory cell pattern, suggests that the nature of the inflammatory process within the lower respiratory tract may be distinctive in these two diseases.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2005.02224.x","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T10:46:39Z","timestamp":1116326799000},"page":"591-597","source":"Crossref","is-referenced-by-count":26,"title":["Bronchoalveolar lavage eosinophil cationic protein and interleukin\u20108 levels in acute asthma and acute bronchiolitis"],"prefix":"10.1111","volume":"35","author":[{"given":"Chang Keun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young\u2010Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinho","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Yull","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,5,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.14-4-134"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6330.1665"},{"key":"e_1_2_6_4_2","first-page":"500","article-title":"Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis","volume":"95","author":"Sigurs N","year":"1995","journal-title":"a prospective cohort study with matched controls"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198110083051501"},{"key":"e_1_2_6_6_2","first-page":"1918","article-title":"Respiratory syncytical virus\u2010induced chemokine expression in the lower airways","volume":"159","author":"Harrison AM","year":"1999","journal-title":"eosinophil recruitment and degranulation"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1998.275.5.L983"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.9.613"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.6.2005116"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.108392"},{"key":"e_1_2_6_11_2","first-page":"1172","article-title":"Eosinophil cationic protein (ECP)","volume":"29","author":"Venge P","year":"1999","journal-title":"molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010113231505"},{"key":"e_1_2_6_13_2","first-page":"11","article-title":"Chemokines and their role in human disease","volume":"46","author":"Kunkel SL","year":"1995","journal-title":"Agents Actions"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.63.6.715"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.133.11.1234"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00331.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00220.x"},{"key":"e_1_2_6_18_2","first-page":"L117","article-title":"Interleukin\u20108 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium","volume":"268","author":"Erger RA","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9806170"},{"key":"e_1_2_6_20_2","first-page":"240","article-title":"Asthma","volume":"67","author":"Warner JO","year":"1992","journal-title":"a follow up statement from an international paediatric asthma consensus group"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64467-4"},{"key":"e_1_2_6_22_2","first-page":"1088","article-title":"Respiratory syncytial virus infection","volume":"132","author":"Kaul A","year":"1978","journal-title":"rapid diagnosis in children by use of indirect immunofluorescence"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80295-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07101865"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.1.7599817"},{"key":"e_1_2_6_26_2","first-page":"245","article-title":"Report of ERS Task Force","volume":"14","author":"Haslam PL","year":"1999","journal-title":"guidelines for measurement of acellular components and standardization of BAL"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.1.91"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2001.012001027.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb01254.x"},{"key":"e_1_2_6_30_2","first-page":"1501","article-title":"Sputum in severe exacerbations of asthma","volume":"155","author":"Pizzichini MM","year":"1997","journal-title":"kinetics of inflammatory indices after prednisone treatment"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.3.9809071"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<261::AID-PPUL5>3.0.CO;2-I"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb00724.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.4.380"},{"key":"e_1_2_6_35_2","first-page":"389","article-title":"Inhibition of interleukin\u20108 expression by dexamethasone in human cultured airway epithelial cells","volume":"81","author":"Kwon OJ","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_6_36_2","first-page":"504","article-title":"The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus","volume":"24","author":"Volovitz B","year":"1988","journal-title":"role in obstructive airway disease"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.4049\/jimmunol.141.12.4291","article-title":"Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation","volume":"141","author":"Tamura N","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80592-X"},{"key":"e_1_2_6_39_2","first-page":"1151","article-title":"Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis","volume":"83","author":"Sigurs N","year":"1994","journal-title":"relation to asthma and atopy"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.4049\/jimmunol.147.12.4307","article-title":"Cytokine (tumor necrosis factor, IL\u20106, and IL\u20108) production by respiratory syncytial virus\u2010infected human alveolar macrophages","volume":"147","author":"Becker S","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/8.1.20"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199510000-00027"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14a23.x"},{"key":"e_1_2_6_44_2","first-page":"35","article-title":"Nasopharyngeal eosinophil cationic protein in bronchiolitis","volume":"24","author":"Reijonen TM","year":"1997","journal-title":"relation to viral findings and subsequent wheezing"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199308000-00010"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2005.02224.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2005.02224.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:13:30Z","timestamp":1697379210000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2005.02224.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1365-2222.2005.02224.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02224.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}